Young-Afat Danny A, Gregorowitsch Madelijn L, van den Bongard Desirée H, Burgmans Ine, van der Pol Carmen C, Witkamp Arjen J, Bijlsma Rhodé M, Koelemij Ron, Schoenmaeckers Ernst J, Jonasse Yvette, van Gils Carla H, Verkooijen Helena M
Imaging Division, University Medical Center, Utrecht, the Netherlands.
Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center, Utrecht, the Netherlands.
JNCI Cancer Spectr. 2019 Apr 16;3(2):pkz011. doi: 10.1093/jncics/pkz011. eCollection 2019 Jun.
The association between lymphedema of the arm and impaired health-related QoL (HR-QoL) has led to changes in clinical practice. However, data on lymphedema of the breast (ie, breast edema) are lacking. We prospectively evaluated patient-reported prevalence and determinants of breast edema and its effect on patient-reported HR-QoL and breast pain.
We prospectively included 836 patients undergoing breast-conserving surgery followed by radiotherapy between October 2013 and October 2016 (UMBRELLA cohort). Patient-reported breast edema, HR-QoL, and breast pain were assessed by means of European Organisation for Research and Treatment of Cancer-C30/BR23 before starting radiotherapy and at 3, 6, 12, and 18 months thereafter. We assessed which patient, tumor, and treatment characteristics were associated with breast edema. With mixed-effects models, we assessed the impact of breast edema on patient-reported HR-QoL domains and breast pain over time, adjusting for confounders.
Within a median follow-up of 28 months (interquartile range [IQR] = 15), 207 (24.8%) patients reported breast edema at some point in time. Prevalence of breast edema was highest at 6 months (12.4%, 95% confidence interval [CI] = 10.0 to 14.7). Larger tumor size, oncoplastic surgery, axillary lymph node dissection, locoregional radiotherapy, radiotherapy boost on the tumor bed, and adjuvant chemotherapy were associated with breast edema. Breast edema was independently associated with more breast pain and with poorer QoL, physical functioning, and body image.
Breast edema occurs frequently within the first year after breast-conserving surgery and radiotherapy and is independently associated with impaired HR-QoL and more breast pain. This information is important for use in clinical practice and should be discussed with patients during shared decision making.
手臂淋巴水肿与健康相关生活质量(HR-QoL)受损之间的关联已导致临床实践发生变化。然而,关于乳腺淋巴水肿(即乳腺水肿)的数据尚缺乏。我们前瞻性地评估了患者报告的乳腺水肿患病率、决定因素及其对患者报告的HR-QoL和乳腺疼痛的影响。
我们前瞻性纳入了2013年10月至2016年10月期间接受保乳手术并随后接受放疗的836例患者(伞形队列)。在放疗开始前以及此后3、6、12和18个月,通过欧洲癌症研究与治疗组织-30/C30-23问卷评估患者报告的乳腺水肿、HR-QoL和乳腺疼痛。我们评估了哪些患者、肿瘤和治疗特征与乳腺水肿相关。使用混合效应模型,我们评估了乳腺水肿随时间对患者报告的HR-QoL领域和乳腺疼痛的影响,并对混杂因素进行了校正。
在中位随访28个月(四分位间距[IQR]=15)内,207例(24.8%)患者在某个时间点报告有乳腺水肿。乳腺水肿患病率在6个月时最高(12.4%,95%置信区间[CI]=10.0至14.7)。肿瘤体积较大、整形手术、腋窝淋巴结清扫、局部区域放疗、瘤床加量放疗以及辅助化疗与乳腺水肿相关。乳腺水肿与更多的乳腺疼痛、较差的生活质量、身体功能和身体形象独立相关。
乳腺水肿在保乳手术和放疗后的第一年内频繁发生,并且与HR-QoL受损和更多的乳腺疼痛独立相关。这些信息对于临床实践具有重要意义,并且在共同决策过程中应与患者进行讨论。